Enteral Stents Market Report 2025

This Enteral Stents market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The enteral stents market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be attributed to factors such as advancements in endoscopic techniques, favorable reimbursement policies, higher surgical success rates, regulatory approvals, and increased awareness of gastrointestinal treatments.

The enteral stents market size is expected to see strong growth in the next few years. It will grow to $2.08 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth during the forecast period can be attributed to factors such as a focus on improving quality of life, advancements in biocompatibility research, green manufacturing practices, the expansion of healthcare insurance, and the adoption of value-based care. Key trends expected in the forecast period include next-generation biodegradable stents, AI-driven stent customization, bioactive stents, wireless communication-enabled stents, and CRISPR-integrated drug delivery systems.

The rising incidence of gastrointestinal disorders is expected to drive the growth of the enteral stents market in the coming years. Gastrointestinal disorders encompass a variety of conditions affecting the digestive system, including the esophagus, stomach, intestines, and related organs, often resulting in symptoms such as pain and discomfort. Factors such as poor dietary habits, higher stress levels, sedentary lifestyles, increased antibiotic usage, and greater exposure to environmental toxins are contributing to the growing prevalence of these disorders. Enteral stents play a crucial role in managing these conditions by providing a minimally invasive solution to relieve blockages, restore the normal flow of food and fluids, and improve digestive function, ultimately enhancing patient comfort and quality of life. For example, a report by Crohn’s and Colitis Canada in June 2023 revealed that approximately 322,600 Canadians, or 0.8% of the population, were living with inflammatory bowel disease (IBD) in 2023, with projections indicating this number could rise to 470,000, or 1.1% of the population, by 2035. As such, the increasing prevalence of gastrointestinal disorders is fueling the growth of the enteral stent market.

The increasing incidence of cancer is expected to drive the growth of the enteral stents market in the future. Cancer refers to a range of diseases marked by the uncontrolled growth and spread of abnormal cells within the body. Factors contributing to the rising prevalence of cancer include an aging population, lifestyle choices, advances in diagnostic techniques, genetic predispositions, and improved healthcare access and awareness. Enteral stents are commonly used to address gastrointestinal obstructions caused by cancer, helping alleviate symptoms such as difficulty swallowing (dysphagia) and ensuring continued nutrient intake. For instance, in February 2024, the World Health Organization projected that by 2050, the number of new cancer cases would exceed 35 million, a 77% increase compared to the estimated 20 million cases in 2022. As a result, the growing prevalence of cancer is contributing to the expansion of the enteral stents market.

In February 2023, Olympus Corporation, a Japan-based company specializing in optics and reprography products, acquired Taewoong Medical Co., Ltd. for $370 million. This acquisition enables Olympus to enhance its gastrointestinal (GI) endotherapy portfolio by incorporating Taewoong's advanced technologies and product range, which includes metallic stents used in a variety of GI procedures. Taewoong Medical Co., Ltd., a South Korea-based medical equipment manufacturer, is known for its enteral stents.

Major players in the enteral stents market are Cardinal Health Inc., Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, AMETEK Inc., Lepu Medical Technology (Beijing) Co Ltd., Endo-Therapeutics Inc., Cook Medical, Micro-Tech (Nanjing) Co Ltd., Merit Medical Systems Inc., ConMed Corporation, GBUK Group Ltd., Biosensors International Group Ltd., Medi-Globe GmbH, BVM Medical Limited, Taewoong Medical Inc., ELLA-CS s.r.o., Mitra Industries Inc., and Hobbs Medical Inc.

North America was the largest region in the enteral stents market in 2024. The regions covered in enteral stents report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the enteral stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Enteral stents are medical devices placed in the digestive tract to relieve blockages or narrowing, often caused by tumors or other gastrointestinal issues. These stents help maintain an open passage for food or waste, offering temporary or long-term relief for patients with conditions such as cancer or Crohn's disease.

The primary types of enteral stents include esophageal stents, gastroduodenal stents, and colon stents. Esophageal stents are specifically designed to keep the esophagus open, allowing food and liquids to pass through. These stents are made from materials such as self-expandable plastic and self-expandable metal, and they are used by various end users, including hospitals, specialty clinics, ambulatory centers, and research facilities.

The enteral stents market research report is one of a series of new reports that provides enteral stents market statistics, including enteral stents industry global market size, regional shares, competitors with an enteral stents market share, detailed enteral stents market segments, market trends and opportunities, and any further data you may need to thrive in the enteral stents industry. This enteral stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enteral stent market consists of sales of metal stents, plastic stents, covered stents, self-expanding stents, and biliary stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.